Want to see FUL full AI Analyst Report?
FUL Stock Chart & Stats
$57.01
$0.84(1.51%)
At close: 4:00 PM EDT
$57.01
$0.84(1.51%)
Day’s Range― - ―
52-Week Range$46.70 - $68.63
Previous CloseN/A
Volume423.16K
Average Volume (3M)936.52K
Market Cap
$2.72B
Enterprise Value$5.05B
Total Cash (Recent Filing)$97.23M
Total Debt (Recent Filing)$2.05B
Price to Earnings (P/E)13.9
Beta0.90
Next Earnings
Jan 20, 2027EPS Estimate
1.36Next Dividend Ex-DateN/A
Dividend Yield1.91%
Share Statistics
EPS (TTM)3.64
Shares Outstanding53,829,120
10 Day Avg. Volume655,869
30 Day Avg. Volume936,523
Financial Highlights & Ratios
PEG Ratio1.21
Price to Book (P/B)1.59
Price to Sales (P/S)0.92
P/FCF Ratio26.25
Enterprise Value/Market Cap1.86
Enterprise Value/Revenue1.42
Enterprise Value/Gross Profit4.33
Enterprise Value/Ebitda9.34
Forecast
1Y Price Target
$62.20Price Target Upside9.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)4.85
Revenue Forecast (FY)$3.61B
Bulls Say, Bears Say
Bulls Say
Margin ExpansionPricing execution and restructuring savings are currently offsetting lower volume and elevated raw-material costs. Expanding gross profit and EBITDA margins can strengthen earnings durability, improve resilience across cycles, and provide funding for ongoing operational investment.
Operational EfficiencyThe multi-year Quantum Leap program offers a structural path to lower conversion costs, better working-capital efficiency, and reduced maintenance capital needs. Its facility consolidation and targeted savings could support sustained margin improvement beyond temporary pricing benefits.
Medical Growth OptionalityThe proposed AMS acquisition would add exposure to surgical tissue bonding, a higher-growth medical market that can diversify H.B. Fuller’s industrial and construction exposure. A larger medical platform may improve portfolio quality and balance cyclicality over time.
Bears Say
Weak Cash ConversionReported profitability is not converting efficiently into cash, limiting the funds available for debt reduction, acquisitions, and internal investment. Persistently weak conversion would leave the company more dependent on financing and less able to absorb demand or cost pressure.
Leverage And Financing BurdenH.B. Fuller already carries meaningful debt, while acquisition financing adds fixed interest obligations before the benefits of AMS are fully realized. Management’s stated deleveraging plan is constructive, but execution remains important because leverage can constrain flexibility.
Volume And Demand VolatilityPricing has supported reported growth, but declining volumes and uneven customer orders indicate underlying demand remains fragile in several end markets. Persistent weakness could limit revenue compounding, reduce operating leverage, and make margin gains more dependent on pricing.
H.B. Fuller Company News
FUL FAQ
What was H.B. Fuller Company’s price range in the past 12 months?
H.B. Fuller Company lowest stock price was $46.70 and its highest was $68.63 in the past 12 months.
What is H.B. Fuller Company’s market cap?
H.B. Fuller Company’s market cap is $2.72B.
When is H.B. Fuller Company’s upcoming earnings report date?
H.B. Fuller Company’s upcoming earnings report date is Jan 20, 2027 which is in 89 days.
How were H.B. Fuller Company’s earnings last quarter?
H.B. Fuller Company released its earnings results on Sep 23, 2026. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.465 by $0.055.
Is H.B. Fuller Company overvalued?
According to Wall Street analysts H.B. Fuller Company’s price is currently Undervalued.
Does H.B. Fuller Company pay dividends?
H.B. Fuller Company pays a Quarterly dividend of $0.245 which represents an annual dividend yield of 1.91%. See more information on H.B. Fuller Company dividends here
What is H.B. Fuller Company’s EPS estimate?
H.B. Fuller Company’s EPS estimate is 1.36.
How many shares outstanding does H.B. Fuller Company have?
H.B. Fuller Company has 53,829,120 shares outstanding.
What happened to H.B. Fuller Company’s price movement after its last earnings report?
H.B. Fuller Company reported an EPS of $1.52 in its last earnings report, beating expectations of $1.465. Following the earnings report the stock price went down -0.418%.
Which hedge fund is a major shareholder of H.B. Fuller Company?
Currently, no hedge funds are holding shares in FUL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
H.B. Fuller Company Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$62.20 (9.10% Upside)
$62.20 (9.10% Upside)
Blogger Sentiment
Neutral
FUL Sentiment 57%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 199.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $94.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.3%
Last 30 Days ▲ 37.0%
Last 30 Days ▲ 37.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.18%
12-Months-Change
Fundamentals
Return on Equity
9.51%
Trailing 12-Months
Asset Growth
5.05%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
H.B. Fuller Company
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and medical and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.
FUL Company Deck
FUL Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was predominantly positive, with strong third-quarter revenue, EBITDA, margin, EPS, cash flow, segment performance, Quantum Leap execution, and progress toward closing the AMS acquisition. The main challenges were lower volumes, volatile demand, elevated raw material costs, supply chain disruption, weakness in electronics, construction, China, and portions of HHC and BAS. Management remained confident in continued growth, margin expansion, savings realization, cash flow improvement, and deleveraging.View all FUL earnings summariesFUL Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$62.20
▲(9.10% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ashland
―
Eastman Chemical
―
PPG Industries
―
RPM International
―
Axalta Coating Systems
―
Ownership Overview
0.39% Insiders
36.52% Mutual Funds
2.17% Other Institutional Investors
26.46% Public Companies and
Individual Investors










